BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9935153)

  • 1. Cloning of the human uroplakin 1B cDNA and analysis of its expression in urothelial-tumor cell lines and bladder-carcinoma tissue.
    Finch JL; Miller J; Aspinall JO; Cowled PA
    Int J Cancer; 1999 Feb; 80(4):533-8. PubMed ID: 9935153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uroplakin gene expression by normal and neoplastic human urothelium.
    Lobban ED; Smith BA; Hall GD; Harnden P; Roberts P; Selby PJ; Trejdosiewicz LK; Southgate J
    Am J Pathol; 1998 Dec; 153(6):1957-67. PubMed ID: 9846985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uroplakin gene expression in normal human tissues and locally advanced bladder cancer.
    Olsburgh J; Harnden P; Weeks R; Smith B; Joyce A; Hall G; Poulsom R; Selby P; Southgate J
    J Pathol; 2003 Jan; 199(1):41-9. PubMed ID: 12474225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uroplakins Ia and Ib, two major differentiation products of bladder epithelium, belong to a family of four transmembrane domain (4TM) proteins.
    Yu J; Lin JH; Wu XR; Sun TT
    J Cell Biol; 1994 Apr; 125(1):171-82. PubMed ID: 8138569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation of a CpG island within the uroplakin Ib promoter: a possible mechanism for loss of uroplakin Ib expression in bladder carcinoma.
    Varga AE; Leonardos L; Jackson P; Marreiros A; Cowled PA
    Neoplasia; 2004; 6(2):128-35. PubMed ID: 15140401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of Upk1a and Upk1b expression is linked to stage progression in urothelial carcinoma of the bladder.
    Kaczmarek K; Plage H; Furlano K; Hofbauer S; Weinberger S; Ralla B; Franz A; Fendler A; de Martino M; Roßner F; Schallenberg S; Elezkurtaj S; Kluth M; Lennartz M; Blessin NC; Marx AH; Samtleben H; Fisch M; Rink M; Slojewski M; Ecke T; Hallmann S; Koch S; Adamini N; Minner S; Simon R; Sauter G; Weischenfeldt J; Klatte T; Schlomm T; Horst D; Zecha H
    Int Urol Nephrol; 2024 Feb; 56(2):499-508. PubMed ID: 37777995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. bc10: A novel human bladder cancer-associated protein with a conserved genomic structure downregulated in invasive cancer.
    Gromova I; Gromov P; Celis JE
    Int J Cancer; 2002 Apr; 98(4):539-46. PubMed ID: 11920613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of transitional cell-specific genes, uroplakin Ia and II, in bladder cancer: detection of circulating cancer cells in the peripheral blood of metastatic patients.
    Yuasa T; Yoshiki T; Isono T; Tanaka T; Hayashida H; Okada Y
    Int J Urol; 1999 Jun; 6(6):286-92. PubMed ID: 10404304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uroplakin 1b is critical in urinary tract development and urothelial differentiation and homeostasis.
    Carpenter AR; Becknell MB; Ching CB; Cuaresma EJ; Chen X; Hains DS; McHugh KM
    Kidney Int; 2016 Mar; 89(3):612-24. PubMed ID: 26880456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of uroplakin Ib and uroplakin III genes in tissues and peripheral blood of patients with transitional cell carcinoma.
    Yuasa T; Yoshiki T; Tanaka T; Kim CJ; Isono T; Okada Y
    Jpn J Cancer Res; 1998 Sep; 89(9):879-82. PubMed ID: 9818021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p15(INK4b) in bladder carcinomas: decreased expression in superficial tumours.
    Le Frère-Belda MA; Cappellen D; Daher A; Gil-Diez-de-Medina S; Besse F; Abbou CC; Thiery JP; Zafrani ES; Chopin DK; Radvanyi F
    Br J Cancer; 2001 Nov; 85(10):1515-21. PubMed ID: 11720438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular cloning and expression of uroplakins in transitional cell carcinoma.
    Yuasa T; Yoshiki T; Isono T; Tanaka T; Okada Y
    Adv Exp Med Biol; 2003; 539(Pt A):33-46. PubMed ID: 15088894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uroplakin IIIb, a urothelial differentiation marker, dimerizes with uroplakin Ib as an early step of urothelial plaque assembly.
    Deng FM; Liang FX; Tu L; Resing KA; Hu P; Supino M; Hu CC; Zhou G; Ding M; Kreibich G; Sun TT
    J Cell Biol; 2002 Nov; 159(4):685-94. PubMed ID: 12446744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large-scale human tissue analysis identifies Uroplakin 1b as a putative diagnostic marker in surgical pathology.
    Reiswich V; Akdeniz G; Lennartz M; Menz A; Chirico V; Hube-Magg C; Fraune C; Bernreuther C; Simon R; Clauditz TS; Sauter G; Uhlig R; Hinsch A; Kind S; Jacobsen F; Möller K; Steurer S; Minner S; Burandt E; Marx AH; Lebok P; Krech T; Dum D
    Hum Pathol; 2022 Aug; 126():108-120. PubMed ID: 35550834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uroplakin II gene is expressed in transitional cell carcinoma but not in bilharzial bladder squamous cell carcinoma: alternative pathways of bladder epithelial differentiation and tumor formation.
    Wu RL; Osman I; Wu XR; Lu ML; Zhang ZF; Liang FX; Hamza R; Scher H; Cordon-Cardo C; Sun TT
    Cancer Res; 1998 Mar; 58(6):1291-7. PubMed ID: 9515818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning of human uroplakin II gene from Chinese transitional cell carcinoma of bladder and construction of its eukaryotic expression vector.
    Chen F; Zeng F; Tong Q; Zheng L; Wang L; Dong J; Lu G
    J Huazhong Univ Sci Technolog Med Sci; 2005; 25(2):188-90, 211. PubMed ID: 16116969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urothelial umbrella cells of human ureter are heterogeneous with respect to their uroplakin composition: different degrees of urothelial maturity in ureter and bladder?
    Riedel I; Liang FX; Deng FM; Tu L; Kreibich G; Wu XR; Sun TT; Hergt M; Moll R
    Eur J Cell Biol; 2005 Mar; 84(2-3):393-405. PubMed ID: 15819416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary bladder transitional cell carcinogenesis is associated with down-regulation of NF1 tumor suppressor gene in vivo and in vitro.
    Aaltonen V; Boström PJ; Söderström KO; Hirvonen O; Tuukkanen J; Nurmi M; Laato M; Peltonen J
    Am J Pathol; 1999 Mar; 154(3):755-65. PubMed ID: 10079253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and methylation-based silencing of a gene (DBCCR1) within a candidate bladder cancer tumor suppressor region at 9q32-q33.
    Habuchi T; Luscombe M; Elder PA; Knowles MA
    Genomics; 1998 Mar; 48(3):277-88. PubMed ID: 9545632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosomal localization of the human urothelial "tetraspan" gene, UPK1B, to 3q13.3-q21 and detection of a TaqI polymorphism.
    Finch JL; Webb GC; Evdokiou A; Cowled PA
    Genomics; 1997 Mar; 40(3):501-3. PubMed ID: 9073521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.